Ariadne Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Ariadne Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$48.9K	Buy	12,311 +354	+3%	+$1.48K	0.02%	255
2026 Q2	$50.3K	Sell	11,957 -607	-5%	-$2.34K	0.02%	250
2026 Q1	$44.1K	Buy	12,564 +340	+3%	+$1.39K	0.02%	245
2025 Q4	$56.4K	Sell	12,224 -17	-0.1%	-$44	0.02%	257
2025 Q3	$41.3K	Sell	12,241 -648	-5%	-$671	0.02%	243
2025 Q2	$14K	Buy	+12,889	New	+$10.1K	0.01%	229

Other funds holding IRWD

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Ariadne Wealth Management's IRWD Position: Q3 2026 in Review

Ariadne Wealth Management increased its Ironwood Pharmaceuticals (IRWD) stake by 3% in Q3 2026, buying an estimated $1.48K and bringing the position to 12,311 shares worth $48.9K. The position accounts for 0.02% of the portfolio, ranked #255.

Ariadne Wealth Management first reported a position in IRWD in Q2 2025 and has held it in 6 quarters since. The position peaked at $56.4K in Q4 2025. 112 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

Ariadne Wealth Management held 12,311 shares of Ironwood Pharmaceuticals worth $48.9K as of Q3 2026.
Ariadne Wealth Management bought 354 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $1.48K.
Ironwood Pharmaceuticals made up 0.02% of Ariadne Wealth Management's portfolio in Q3 2026, its #255 holding.
Ariadne Wealth Management first reported a position in Ironwood Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
Ariadne Wealth Management's Ironwood Pharmaceuticals position peaked at $56.4K in Q4 2025.
112 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Ariadne Wealth Management's 13F filing for Q3 2026, filed 6 Nov 2026.